Literature DB >> 17138785

Recurrence of clinical chorioamnionitis in subsequent pregnancies.

Vanessa R Laibl1, Jeanne S Sheffield, Scott Roberts, Donald D McIntire, George D Wendel.   

Abstract

OBJECTIVE: To establish the role of clinical chorioamnionitis as an independent risk factor for recurrence in a subsequent pregnancy.
METHOD: This was a historical cohort study of pregnant women who had their first and second deliveries at our institution between January 1988 and May 2005. The index pregnancy was restricted to those who delivered vaginally. Data were collected from a continuously updated obstetric database and included demographic and labor characteristics and neonatal outcomes. Chorioamnionitis was diagnosed clinically.
RESULTS: The study population consisted of 23,397 women. During the index pregnancy, 10% of women developed chorioamnionitis. This group was significantly different from the rest of the cohort in terms of age, ethnicity, length of labor, epidural analgesia, use of internal monitors, and incidence of prolonged rupture of membranes. In the second pregnancy, 6% of those women again developed chorioamnionitis compared with 2% of women who did not have chorioamnionitis in the first pregnancy (odds ratio 2.93, 95% confidence interval 2.40-3.57). After adjusting for the above confounders, the increased risk of recurrence persisted (odds ratio 1.85, 95% confidence interval 1.49-2.30).
CONCLUSION: Women delivering vaginally who were diagnosed with chorioamnionitis during their first pregnancy are at increased risk for chorioamnionitis in a subsequent pregnancy. This supports the concept that there may be a predisposition to chorioamnionitis that should be further investigated. LEVEL OF EVIDENCE: II-2.

Entities:  

Mesh:

Year:  2006        PMID: 17138785     DOI: 10.1097/01.AOG.0000247647.88489.b0

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  5 in total

1.  Histological villous maturation in placentas of complicated pregnancies.

Authors:  Philippe Vangrieken; Sizzle F Vanterpool; Frederik J van Schooten; Salwan Al-Nasiry; Peter Andriessen; Ellen Degreef; Joachim Alfer; Boris W Kramer; Ulrike von Rango
Journal:  Histol Histopathol       Date:  2020-01-27       Impact factor: 2.303

2.  MATERNAL AND NEONATAL OUTCOMES OF HISTOLOGICAL CHORIOAMNIONITIS.

Authors:  A N Ocheke; I E Ocheke; P A Agaba; G E Imadde; O A Silas; O I Ajetunmobi; Eche John Godwins; C Ekere; A Sendeht; J Bitrus; E I Agaba; A S Sagay
Journal:  J West Afr Coll Surg       Date:  2016 Jul-Sep

3.  Chorioamnionitis in pregnancy: a comparative study of HIV-positive and HIV-negative parturients.

Authors:  Amaka N Ocheke; Patricia A Agaba; Godwin E Imade; Olugbenga A Silas; Olanrewaju I Ajetunmobi; Godwins Echejoh; Clement Ekere; Ayuba Sendht; James Bitrus; Emmanuel I Agaba; Atiene S Sagay
Journal:  Int J STD AIDS       Date:  2015-04-16       Impact factor: 1.359

4.  A population-based study of the risk of repeat clinical chorioamnionitis in Washington State, 1989-2008.

Authors:  Hannah N Cohen-Cline; Talia R Kahn; Carolyn M Hutter
Journal:  Am J Obstet Gynecol       Date:  2012-08-17       Impact factor: 8.661

5.  Recurrence of premature rupture of membranes among pregnancies admitted to a Tertiary Hospital: a retrospective cohort study.

Authors:  Deniz Suzme; Sinan Ates; Cem Yener; G Fusun Varol
Journal:  Arch Gynecol Obstet       Date:  2022-03-13       Impact factor: 2.344

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.